Cargando…
The influence of different blood samples treatment methods on pro-gastrin-releasing peptide
Pro-gastrin-releasing peptide (ProGRP) is the promising molecular tumor marker of small cell lung cancer (SCLC). Here we study the influence of different blood samples treatment methods on ProGRP. Serum with and without separation gel and heparin plasma from 10 SCLC patients and 5 healthy individual...
Autores principales: | Jiang, Huiqin, Luo, Ling, Xiong, Kang, He, Chengwen, Wang, Huaizhou, Qin, Yanghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6617394/ https://www.ncbi.nlm.nih.gov/pubmed/31261534 http://dx.doi.org/10.1097/MD.0000000000016130 |
Ejemplares similares
-
Pro-Gastrin-Releasing Peptide as a Biomarker in Lung Neuroendocrine Neoplasm
por: Rosiek, Violetta, et al.
Publicado: (2023) -
Evaluation of chemiluminescent immunoassay quantitative detection for pro-gastrin-releasing peptide (ProGRP) in serum and plasma
por: Cheng, Yizhuang, et al.
Publicado: (2019) -
Exploring the application value of pro‐gastrin‐releasing peptide in the clinical diagnosis and surgical treatment of medullary thyroid carcinoma
por: Miao, Qiang, et al.
Publicado: (2023) -
Paclitaxel-loaded nanobubble targeted to pro-gastrin-releasing peptide inhibits the growth of small cell lung cancer
por: Wang, Jin-Ping, et al.
Publicado: (2019) -
Gastrin-Releasing Peptide and Glucose Metabolism Following Pancreatitis
por: Pendharkar, Sayali A., et al.
Publicado: (2017)